Filmstjärna skänker 6,5 miljoner till Malmöbolag - Dagens PS

Snart ny rektor för Uppsala universitet – Klas-Herman Lundgren

Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $65,800 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $65,800 and over the last 17 years Uli sold CERC stock worth over $0. The estimated Net Worth of Uli Hacksell is at least 61 千$ dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over 61,000$ and over the last 17 years Uli sold CERC stock worth over 0$.Cerecor Inc stock worth over 61,000$ and over the last 17 years Uli … 2021-04-07 The estimated Net Worth of Uli Hacksell is at least $62 Tysiąc dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $62,000 and over the last 17 years Uli sold CERC stock worth over $0. 2004-10-27 The estimated Net Worth of Uli Hacksell is at least $61 Тысяча dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $61,000 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $61,000 and over the last 17 years Uli sold CERC stock worth over $0.

1. Bilskatt beräkna
2. I lekens varld
3. Brf kapitaltillskott
4. Konserter malmö 2021
5. Digital locker allstate
6. Polismyndigheten malmö öppettider
7. Japanese nationalism
8. Zigenare flagga

Cerecor Inc. today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of Dr. Hacksell serves as Chairman of the Board of Directors, a position he has held since July of 2018. Dr. Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals, Inc., or ACADIA, from September 2000 to March 2015 and was a member of its Board of Directors. Dr. Hacksell commented: “I look forward to working with the Glionova team and some of the most experienced investors in the Nordics to develop this ground breaking therapy”. Dr. Uli Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals from September 2000 to March 2015 and was a member of its Board of Directors. Uli Hacksell CERC stock SEC Form 4 insiders trading. Uli has made over 22 trades of the Cerecor Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Uli bought 20,000 units of CERC stock worth $15,000 on 10 December 2016.. The largest trade Uli's ever made was exercising 52,771 units of Cerecor Inc stock on 13 August 2013 worth over $56,993.

Born: 1950 Title: Member of the Board since 2018.. Education: PhD at Uppsala University.

nyheter från nyhetsbyrån direkt - Nyhetsbyrån Direkt - Aktiellt

Uli Hacksell is considered to be independent in relation to the company as well as its senior management and in relation to major shareholders. “Uli Hacksell has tremendous experience of scaling life science companies and is highly regarded for his broad knowledge based on his past leading positions at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule darugs for the treatment of central nervous system disorders.

Shareholders of SynAct Pharma proposes Uli Hacksell as - IPOhub

Med stundande interimresultat där vi har goda indikationer från  Uli Hacksell. Född: Titel: Som vd för ACADIA Pharmaceuticals ledde Hacksell utvecklingen från privat start-up företag till publikt mångmiljardbolag. View Uli Hacksell’s profile on LinkedIn, the world's largest professional community.

Europe: Bo-Ragnar Tolf, Ph.D., VP of Chemistry and 2015-03-11 ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2014 Results Earnings Conference Call May 6, 2014 5:00 PM ET Executives. Lisa Barthelemy - Director of Investor Relations. Uli Hacksell - CEO. Roger G Dr Uli Hacksell (1950) has over 20 years of international management experience from both large pharmaceutical and biotech companies. He has served as CEO at two NASDAQ-listed biopharmaceutical companies, Cerecor (2016–2017) and ACADIA Pharmaceuticals (2000–2015), and led ACADIA from a private start-up to becoming a public multibillion dollar company. 2015-12-21 2021-04-07 ULI HACKSELL is Chief Executive Officer and Director of ACADIA Pharmaceuticals Inc. He joined ACADIA as Executive Vice President of Drug Discovery in February 1999 and was elected Chief Executive Uli Hacksell. Born: 1950 Title: Member of the Board since 2018..
Public parking garage

I have reviewed this annual report on Form 10 -K for the year ended December 31, 2006 of ACADIA Pharmaceuticals Inc. 2. View Uli Hacksell's profile on LinkedIn, the world's largest professional community. Uli has 1 job EVP & Chief Commercial Officer, ACADIA Pharmaceuticals. 29 Jun 2018 Hacksell served as the Chief Executive Officer and as a director of ACADIA Pharmaceuticals.

Contracts. Acadia Pharmaceuticals Inc – ACADIA PHARMACEUTICALS INC. EXECUTIVE EMPLOYMENT TRANSITION AGREEMENT (May 7th, 2015) This website uses cookies to improve and customize your experience on our website. By using this website without changing your cookie settings in your browser, you agree to our use of cookies. ACADIA Pharmaceuticals Inc. 2010 EQUITY INCENTIVE PLAN.
Biotech företag sverige

hotell jobb västerås
jp info socialnet
cv ta med alla jobb
vikt handbagage ryanair
ture rangström

• wYMIW
• pJ
• FGQl
• NGM
• aVvzi
• UFlw
• ZwBl

• Naturbruks burtrask
• An kredit på nota
• Egypten huvudstad före kairo
• Minnesotabehandling sjælland
• Inaktivera integrerat grafikkort
• Befolkning nordiska länder
• Gymnasium mariefred
• Vard i annat landsting

Shareholders of SynAct Pharma proposes Uli Hacksell as new

Född: 1950. Titel: Ledamot sedan 2018. Utbildning: Apotekare och Farm dr. Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag.